Beverly Hills Private Wealth’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $226K | Sell |
938
-75
| -7% | -$18.1K | 0.04% | 309 |
|
|
2025
Q1 | $247K | Buy |
1,013
+12
| +1% | +$2.92K | 0.05% | 300 |
|
|
2024
Q4 | $329K | Sell |
1,001
-129
| -11% | -$42.4K | 0.07% | 240 |
|
|
2024
Q3 | $378K | Sell |
1,130
-204
| -15% | -$68.2K | 0.08% | 225 |
|
|
2024
Q2 | $364K | Buy |
1,334
+111
| +9% | +$30.3K | 0.08% | 240 |
|
|
2024
Q1 | $423K | Buy |
1,223
+310
| +34% | +$107K | 0.1% | 223 |
|
|
2023
Q4 | $295K | Sell |
913
-170
| -16% | -$54.9K | 0.08% | 259 |
|
|
2023
Q3 | $388K | Sell |
1,083
-736
| -40% | -$264K | 0.12% | 191 |
|
|
2023
Q2 | $728K | Buy |
1,819
+946
| +108% | +$378K | 0.12% | 186 |
|
|
2023
Q1 | $418K | Buy |
873
+130
| +17% | +$62.3K | 0.13% | 173 |
|
|
2022
Q4 | $312K | Buy |
+743
| New | +$312K | 0.14% | 171 |
|